vidarabine phosphate and Bladder Cancer

vidarabine phosphate has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bochner, BH; Cordon-Cardo, C; Kasahara, N; Kikuchi, E; Logg, CR; Menendez, S; Ohori, M; Ozu, C1

Other Studies

1 other study(ies) available for vidarabine phosphate and Bladder Cancer

ArticleYear
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Cancer gene therapy, 2007, Volume: 14, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; DNA Replication; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Leukemia Virus, Murine; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vidarabine Phosphate

2007